Bio News
Chinese researchers identified that liver cancer cells produce hemoglobin under hypoxic conditions, leading to sorafenib resistance.
Liver cancer cells expressed hemoglobin through the HIF-1α-KLF4 pathway to eliminate reactive oxygen species.
Inhibiting hemoglobin enhanced the anticancer effects of sorafenib and lenvatinib in an animal model.
Biobook Team
biobookmedia@biobook.co.krParagon Spin-Off Velaris Goes Public Through Reverse Merger With Alaunos
Syndax halts development of Niktimvo for pulmonary fibrosis; shares plunge 17%
BioNTech’s mRNA Cancer Vaccine Misses Primary Endpoint for Progression-Free Survival in Phase 3 Trial
Roche Signs $1.6 Billion Deal With China’s Rona for ALK7 Obesity Drug
Formycon and Zydus’ Keytruda Biosimilar Is First to Be Accepted for FDA Review
Pfizer Signs $500 Million Protein Degrader Deal With Enodia
